Teladoc, GoodRx shares fall on OpenAI health feature launch By Investing.com
Teladoc (NYSE:TDOC) and GoodRx (NASDAQ:GDRX) shares fell about 2.8% and 2.6% after OpenAI launched a ChatGPT health feature that lets US users connect Apple Health data and medical records from supported providers. OpenAI said it has over 300 million weekly health-related ChatGPT users and that data is encrypted and not used to train models.
How this was made
The 30-second read
Why it matters
The article frames a same-day selloff in Teladoc and GoodRx as investors react to potential competitive pressure from AI-driven health-data analysis and summarization.
Market read
This is primarily a market-reaction piece to an OpenAI product launch, with no direct Teladoc or GoodRx business update provided.
What to watch
The article states connected records are not used to train models and that users can disconnect; competitive impact may be smaller than the market reaction implies.
Background
OpenAI announced a ChatGPT health feature that lets US users connect Apple Health and medical records from supported hospital systems, One Medical, and Function Health.
Ticker impact
Teladoc shares fell 2.8% after OpenAI launched a ChatGPT health feature that connects medical records and Apple Health data.
Near-term downside pressure is plausible if investors treat the feature as competitive to Teladoc’s data and care workflows.
The only TDOC-specific element is the same-day price drop; the rest is OpenAI product news with no direct linkage to Teladoc revenue or partnerships.
GoodRx shares declined 2.6% alongside Teladoc after OpenAI announced ChatGPT health features that integrate connected records and Apple Health.
Likely continued volatility until the market clarifies whether the feature meaningfully disintermediates GoodRx’s services.
The article ties the price move to OpenAI’s launch but does not cite any GoodRx product, contract, or customer impact.
Market effects
AI health assistants integrating medical records could pressure digital health and patient-navigation business models, at least at the margin.
US-listed digital health stocks show same-day downside tied to an AI product catalyst.
Limited beyond US peers, since the feature is described as US-available and tied to Apple Health and specific hospital systems.
Counterpoint
The feature may increase demand for healthcare guidance and could complement telehealth and medication-navigation platforms rather than replace them.
Key entities
- companyOpenAI
Announced ChatGPT health feature integrating Apple Health and connected medical records for US users.
- companyTeladoc
Digital health provider whose shares fell 2.8% in the article’s market reaction.
- companyGoodRx
Prescription savings and healthcare navigation company whose shares fell 2.6% in the article’s market reaction.
